Matthew Arnold

2.1k total citations
46 papers, 565 citations indexed

About

Matthew Arnold is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Surgery. According to data from OpenAlex, Matthew Arnold has authored 46 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 15 papers in Nephrology and 9 papers in Surgery. Recurrent topics in Matthew Arnold's work include Chronic Kidney Disease and Diabetes (14 papers), Blood Pressure and Hypertension Studies (11 papers) and Dialysis and Renal Disease Management (7 papers). Matthew Arnold is often cited by papers focused on Chronic Kidney Disease and Diabetes (14 papers), Blood Pressure and Hypertension Studies (11 papers) and Dialysis and Renal Disease Management (7 papers). Matthew Arnold collaborates with scholars based in United Kingdom, United States and Sweden. Matthew Arnold's co-authors include Hungta Chen, Krister Järbrink, Robert Clarke, Kuppan Gokulan, Sangeeta Khare, Sarah Parish, Carl E. Cerniglia, Michelle M. Vanlandingham, Daniel R. Doerge and Jennifer Carter and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Matthew Arnold

44 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Arnold United Kingdom	13	139	115	100	87	79	46	565
Lishun Liu China	13	200 1.4×	52 0.5×	68 0.7×	78 0.9×	46 0.6×	78	547
Linsay McCallum United Kingdom	13	275 2.0×	133 1.2×	82 0.8×	84 1.0×	49 0.6×	33	660
Yeonhee Lee South Korea	15	127 0.9×	197 1.7×	63 0.6×	88 1.0×	84 1.1×	34	630
Shaochen Guan China	13	133 1.0×	79 0.7×	122 1.2×	61 0.7×	51 0.6×	32	605
Yingxin Zhao China	17	317 2.3×	53 0.5×	86 0.9×	96 1.1×	135 1.7×	45	690
Saeed K. Shaffi United States	10	96 0.7×	456 4.0×	73 0.7×	57 0.7×	45 0.6×	24	755
Chunxiu Wang China	14	134 1.0×	48 0.4×	92 0.9×	56 0.6×	65 0.8×	60	646
Christina Park United States	13	45 0.3×	210 1.8×	62 0.6×	38 0.4×	31 0.4×	44	570
Cassandra Becker United States	3	97 0.7×	215 1.9×	61 0.6×	59 0.7×	25 0.3×	3	552
Ailema González-Ortíz Mexico	8	63 0.5×	275 2.4×	115 1.1×	35 0.4×	126 1.6×	23	616

Countries citing papers authored by Matthew Arnold

Since Specialization

Citations

This map shows the geographic impact of Matthew Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Arnold more than expected).

Fields of papers citing papers by Matthew Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Arnold. The network helps show where Matthew Arnold may publish in the future.

Co-authorship network of co-authors of Matthew Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Arnold. A scholar is included among the top collaborators of Matthew Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Arnold. Matthew Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paige, Ellie, Michael Sweeting, Juliet A. Usher‐Smith, et al.. (2025). Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study. BMJ Public Health. 3(1). e001241–e001241. 1 indexed citations

Heerspink, Hiddo J.L., Stephen Nolan, Juan Jesús Carrero, et al.. (2024). Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort. Advances in Therapy. 41(8). 3264–3277. 5 indexed citations

Maier, Hannah E., Theresa Kowalski-Dobson, Ashley Eckard, et al.. (2024). Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults. Open Forum Infectious Diseases. 11(2). ofae039–ofae039. 5 indexed citations

Challoumas, Dimitris, Catherine Simpson, Matthew Arnold, et al.. (2024). Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping review. Autoimmunity Reviews. 24(3). 103736–103736. 1 indexed citations

Chung, Ryan, Zhe Xu, Matthew Arnold, et al.. (2023). Using Polygenic Risk Scores for Prioritizing Individuals at Greatest Need of a Cardiovascular Disease Risk Assessment. Journal of the American Heart Association. 12(15). e029296–e029296. 8 indexed citations

Chung, Ryan, Zhe Xu, Matthew Arnold, et al.. (2023). Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care records. PLoS ONE. 18(9). e0292240–e0292240. 4 indexed citations

Sánchez, Juan José García, Glen James, Juan Jesús Carrero, et al.. (2023). Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort. Kidney International Reports. 8(4). 785–795. 14 indexed citations

Pecoits‐Filho, Roberto, Maria Cristina Ribeiro de Castro, Ana Cebrián, et al.. (2023). #3667 REVEAL-CKD: PREVALENCE OF UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN AUSTRALIA, BRAZIL, CANADA AND SPAIN. Nephrology Dialysis Transplantation. 38(Supplement_1). 2 indexed citations

Müllerová, Hana, Jennie Medin, Matthew Arnold, et al.. (2023). Background rate estimations for thrombosis with thrombocytopaenia: challenges in evaluating rare safety signals following vaccination in real time during a pandemic. BMJ Open. 13(1). e063645–e063645.

10.

Kanda, Eiichiro, Anjay Rastogi, Toyoaki Murohara, et al.. (2023). Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrology. 24(1). 18–18. 26 indexed citations

11.

Kanda, Eiichiro, Charles V. Pollack, Anjay Rastogi, et al.. (2023). #3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

12.

Tangri, Navdeep, Markus P. Schneider, Luca De Nicola, et al.. (2023). Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open. 13(5). e067386–e067386. 66 indexed citations

13.

Xu, Zhe, Matthew Arnold, Luanluan Sun, et al.. (2022). Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records. International Journal of Epidemiology. 51(6). 1813–1823. 2 indexed citations

14.

Arnold, Matthew, et al.. (2022). Developing a common data model approach for DISCOVER CKD: A retrospective, global cohort of real-world patients with chronic kidney disease. PLoS ONE. 17(9). e0274131–e0274131. 5 indexed citations

15.

Vyshedskiy, Andrey, et al.. (2022). Boston cognitive assessment (BOCA) — a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance. BMC Neurology. 22(1). 92–92. 14 indexed citations

16.

James, Glen, Juan José García Sánchez, Juan Jesús Carrero, et al.. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney International Reports. 7(9). 2059–2070. 22 indexed citations

17.

Arnold, Matthew, Alison Offer, Marion Mafham, et al.. (2021). A Biomarker-based Biological Age in UK Biobank: Composition and Prediction of Mortality and Hospital Admissions. The Journals of Gerontology Series A. 76(7). 1295–1302. 35 indexed citations

18.

Wittbrodt, Eric, Salvatore Barone, Matthew Arnold, et al.. (2021). REVEAL-CKD: Prevalence of Undiagnosed Early CKD in France and Japan. Journal of the American Society of Nephrology. 32(10S). 715–716. 1 indexed citations

19.

Littlejohns, Thomas J., Amanda Y. Chong, Naomi E. Allen, et al.. (2020). Genetic, lifestyle, and health-related characteristics of adults without celiac disease who follow a gluten-free diet: a population-based study of 124,447 participants. American Journal of Clinical Nutrition. 113(3). 622–629. 9 indexed citations

20.

Blossom, Sarah J., Kuppan Gokulan, Matthew Arnold, & Sangeeta Khare. (2020). Sex-Dependent Effects on Liver Inflammation and Gut Microbial Dysbiosis After Continuous Developmental Exposure to Trichloroethylene in Autoimmune-Prone Mice. Frontiers in Pharmacology. 11. 569008–569008. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact